Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 24, 2013 - Issue 1
Submit an article Journal homepage
657
Views
24
CrossRef citations to date
0
Altmetric
Psoriasis

Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature

SATVEER K. MahilSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK
,
THOMASIN C. AndrewsDepartment of Neurology, Guy's and St Thomas' NHS Foundation Trust, London, UK
,
CHARLOTTE BrierleyDepartment of Neurology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
,
JONATHAN N. BarkerSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK
&
CATHERINE H. SmithSt John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UKCorrespondence[email protected]
Pages 38-49 | Received 28 Nov 2011, Accepted 08 Dec 2011, Published online: 11 Mar 2012

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tessa Hanley, Marc Handford, Dawn Lavery & Zenas ZN Yiu. (2016) Assessment and monitoring of biologic drug adverse events in patients with psoriasis. Psoriasis: Targets and Therapy 6, pages 41-54.
Read now
Tian Hao Zhu, Mio Nakamura, Michael Abrouk, Benjamin Farahnik, John Koo & Tina Bhutani. (2016) Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review. Journal of Dermatological Treatment 27:5, pages 406-413.
Read now
Reena Khanna & Brian G Feagan. (2015) Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events. Expert Opinion on Drug Safety 14:6, pages 987-997.
Read now

Articles from other publishers (21)

J.M. Carrascosa, L. Puig, I.B. Romero, L. Salgado-Boquete, E. del Alcázar, J.J.A. Lencina, D. Moreno & P. de la Cueva. (2022) [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of Special Populations, Patients With Comorbid Conditions, and Risk. Actas Dermo-Sifiliográficas 113:6, pages T583-T609.
Crossref
J.M. Carrascosa, L. Puig, I.B. Romero, L. Salgado-Boquete, E. del Alcázar, J.J.A. Lencina, D. Moreno & P. de la Cueva. (2022) Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo». Actas Dermo-Sifiliográficas 113:6, pages 583-609.
Crossref
Nicholas Stienstra, Joel Horton, Michael Lane, Anand Kumthekar, Nishad Sathe, Christy Sunny, Vijayshree Yadav & Atul Deodhar. (2022) Demyelinating Disease After Exposure to Tumor Necrosis Factor α Inhibitors. JCR: Journal of Clinical Rheumatology 28:2, pages e638-e641.
Crossref
Marina Romozzi, Simone Bellavia, Giacomo Caldarola, Clara De Simone, Marco Luigetti, Paolo Calabresi, Massimiliano Di Filippo, Carlo Masullo & Matteo Lucchini. (2021) Ixekizumab exposure associated with myelitis: A case report and a literature review. Journal of Neuroimmunology 361, pages 577726.
Crossref
A. Nast, C. Smith, P.I. Spuls, G. Avila Valle, Z. Bata‐Csörgö, H. Boonen, E. De Jong, I. Garcia‐Doval, P. Gisondi, D. Kaur‐Knudsen, S. Mahil, T. Mälkönen, J.T. Maul, S. MburuU. Mrowietz, K. Reich, E. Remenyik, K.M. Rønholt, P.G. Sator, M. Schmitt‐Egenolf, M. Sikora, K. Strömer, O. Sundnes, D. TrigosG. Van Der Kraaij, N. Yawalkar & C. Dressler. (2021) EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations. Journal of the European Academy of Dermatology and Venereology 35:2, pages 281-317.
Crossref
Tine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Sellebjerg, Rene Lindholm Cordtz, Dorte V Jensen, Johan Askling & Lene Dreyer. (2020) Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden. Annals of the Rheumatic Diseases 79:5, pages 566-572.
Crossref
Reena Khanna, Barrett G. Levesque, John W.D. McDonald & Brian G. Feagan. 2019. Evidence-based Gastroenterology and Hepatology 4e. Evidence-based Gastroenterology and Hepatology 4e 150 172 .
J. M. E. Boggs & L. Barnes. (2018) Demyelination during anti-tumour necrosis factor therapy for psoriasis. Clinical and Experimental Dermatology 43:5, pages 577-578.
Crossref
Martin Havmose & Simon Francis Thomsen. (2017) Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases. International Journal of Dermatology 56:11, pages 1087-1102.
Crossref
Ippazio Cosimo Antonazzo, Emanuel Raschi, Luca Vignatelli, Elisa Baldin, Trond Riise, Roberto D’Alessandro, Fabrizio De Ponti & Elisabetta Poluzzi. (2017) Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping. Drug Safety 40:9, pages 823-834.
Crossref
Karen L. Lankford, Edgardo J. Arroyo & Jeffery D. Kocsis. (2017) Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells. Neurochemical Research 42:9, pages 2595-2609.
Crossref
Malihe Eskandarpour, Robert Alexander, Peter Adamson & Virginia L. Calder. (2017) Pharmacological Inhibition of Bromodomain Proteins Suppresses Retinal Inflammatory Disease and Downregulates Retinal Th17 Cells. The Journal of Immunology 198:3, pages 1093-1103.
Crossref
Judith Günther & Uwe Fricke. 2017. Arzneiverordnungs-Report 2017. Arzneiverordnungs-Report 2017 431 476 .
Melinda Liu, Yuan Yu M. Huang, Sylvia Hsu & Joseph S. Kass. (2016) Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs 30:12, pages 1149-1168.
Crossref
L Dreyer, M Magyari, B Laursen, R Cordtz, F Sellebjerg & H Locht. (2016) Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry. Annals of the Rheumatic Diseases 75:4, pages 785-786.
Crossref
Satveer K. Mahil, Francesca Capon & Jonathan N. Barker. (2015) Update on psoriasis immunopathogenesis and targeted immunotherapy. Seminars in Immunopathology 38:1, pages 11-27.
Crossref
Judith Günther & Uwe Fricke. 2016. Arzneiverordnungs-Report 2016. Arzneiverordnungs-Report 2016 427 470 .
Judith Günther & Uwe Fricke. 2015. Arzneiverordnungs-Report 2015. Arzneiverordnungs-Report 2015 589 659 .
Juan Escalas, Nicole Knöpfel, Ana Martin-Santiago & Carmen Calles. (2014) Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis. Journal of the American Academy of Dermatology 70:1, pages e17-e18.
Crossref
Uwe Fricke. 2014. Arzneiverordnungs- Report 2014. Arzneiverordnungs- Report 2014 581 649 .
. (2013) Adalimumab/etanercept. Reactions Weekly 1448:1, pages 5-5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.